News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mazyar Shadman is starting a new position as medical director at Fred Hutch Cancer Centre
Photo of Mazyar Shadman taken from bloodcancerstoday.com
Jul 14, 2024, 08:04

Mazyar Shadman is starting a new position as medical director at Fred Hutch Cancer Centre

Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Medical Director, Cellular Immunotherapy at Fred Hutch Cancer Centre!”

Source: Mazyar Shadman/LinkedIn

cancer cellular immunotherapy Fred Hutch Cancer Centre Mazyar Shadman OncoDaily Oncology
Blog
Aug 25, 2024, 20:23
First recommendations from the ESMO/ SIOG about Geriatric Assessment and Personalised Care
Blog
Aug 25, 2024, 20:14
CPOEM Foundation's first support group webinar for patients with multiple myeloma
Blog
Aug 25, 2024, 20:10
Urgent need for new therapies for colorectal cancer patients with MSS disease - Agenus
Blog
Aug 25, 2024, 20:04
Olubukola Ayodele is nominated for a UHL Recognition Award 2024
Blog
Aug 25, 2024, 19:57
Miriam Mutebi: "Can food cure cancer?"
Blog
Aug 25, 2024, 19:47
Paxman Scalp Cooling's Q2 2024 report
Blog
Aug 25, 2024, 19:31
Mark Lawler: Time to defuse the ticking time bomb
Blog
Aug 25, 2024, 19:25
Excellent review of clinical trials involving inhibition of immune checkpoints and Radiotherapy
Dialogues
Aug 25, 2024, 17:20
Beyond The Cancer Diagnosis: Dialogue with Sonia Amin Thomas, Hosted By Adrian Pogacian
Blog
Aug 25, 2024, 17:04
Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka
Blog
Aug 25, 2024, 16:51
Mark Lewis: A hard-fought remission that ushers in constant fear is a Pyrrhic victory
Blog
Aug 25, 2024, 16:46
Paola Alberti: Neuroprotection against of Molsidomine against vincristine-induced peripheral neurotoxicity